Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2019, Article ID 8101503, 3 pages
https://doi.org/10.1155/2019/8101503
Editorial

Sjögren’s Syndrome: Animal Models, Etiology, Pathogenesis, Clinical Subtypes, and Diagnosis

1University at Buffalo, Buffalo, USA
2Peking University People’s Hospital, Beijing, China
3Scheie Eye Institute, University of Pennsylvania, Philadelphia, USA

Correspondence should be addressed to Long Shen; ude.olaffub@lnehs

Received 9 May 2019; Accepted 9 May 2019; Published 20 May 2019

Copyright © 2019 Long Shen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. I. Fox, “Sjögren’s syndrome,” The Lancet, vol. 366, no. 9482, pp. 321–331, 2005. View at Publisher · View at Google Scholar
  2. M. Ramos-Casals, P. Brito-Zerón, R. Seror et al., “Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements,” Rheumatology, vol. 54, no. 12, pp. 2230–2238, 2015. View at Publisher · View at Google Scholar
  3. A. S. Malladi, K. E. Sack, S. C. Shiboski et al., “Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an International Sjögren's syndrome registry,” Arthritis Care & Research, vol. 64, no. 6, pp. 911–918, 2012. View at Publisher · View at Google Scholar
  4. F. Vivino, V. Y. Bunya, G. Massaro-Giordano et al., “Sjogren’s syndrome: an update on disease pathogenesis, clinical manifestations and treatment,” Clinical Immunology, vol. 203, pp. 81–121, 2019, Epub 2019/04/26. View at Publisher · View at Google Scholar
  5. Sjogren’s Syndrome Foundation – Diagnosis, “Sjogren’s Syndrome Foundation, Inc.,” 2018, https://www.sjogrens.org/home/about-sjogrens/diagnosis.
  6. J. Q. Chen, P. Szodoray, and M. Zeher, “Toll-like receptor pathways in autoimmune diseases,” Clinical Reviews in Allergy and Immunology, vol. 50, no. 1, pp. 1–17, 2016. View at Publisher · View at Google Scholar
  7. J. C. Hall, A. N. Baer, A. A. Shah et al., “Molecular subsetting of interferon pathways in Sjögren’s syndrome,” Arthritis & Rheumatology, vol. 67, no. 9, pp. 2437–2446, 2015. View at Publisher · View at Google Scholar
  8. J. Kiripolsky, L. G. McCabe, and J. M. Kramer, “Innate immunity in Sjögren's syndrome,” Clinical Immunology, vol. 182, pp. 4–13, 2017. View at Publisher · View at Google Scholar
  9. A. B. Peck and C. Q. Nguyen, “What can Sjögren's syndrome-like disease in mice contribute to human Sjögren's syndrome?” Clinical Immunology, vol. 182, pp. 14–23, 2017. View at Publisher · View at Google Scholar
  10. P. Sandhya, B. Kurien, D. Danda, and R. Scofield, “Update on pathogenesis of Sjogren’s syndrome,” Current Rheumatology Reviews, vol. 13, no. 1, pp. 5–22, 2017. View at Publisher · View at Google Scholar
  11. N. Holdgate and E. W. S. Clair, “Recent advances in primary Sjogren’s syndrome,” F1000Research, vol. 5, 2016. View at Publisher · View at Google Scholar
  12. X. Mariette, S. Roux, J. Zhang et al., “The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren’s syndrome,” Annals of the Rheumatic Diseases, vol. 62, no. 2, pp. 168–171, 2003. View at Publisher · View at Google Scholar
  13. L. Shen and L. Suresh, “Autoantibodies, detection methods and panels for diagnosis of Sjögren’s syndrome,” Clinical Immunology, vol. 182, pp. 24–29, 2017. View at Publisher · View at Google Scholar
  14. L. Shen, C. Zhang, T. Wang et al., “Development of Autoimmunity in IL-14α-Transgenic Mice,” The Journal of Immunology, vol. 177, no. 8, pp. 5676–5686, 2006. View at Publisher · View at Google Scholar
  15. R. Evans, A. Zdebik, C. Ciurtin, and S. B. Walsh, “Renal involvement in primary Sjögren’s syndrome,” Rheumatology, vol. 54, no. 9, pp. 1541–1548, 2015. View at Publisher · View at Google Scholar
  16. H. X. Yang, J. Wang, Y. B. Wen et al., “Renal involvement in primary Sjögren's syndrome: A retrospective study of 103 biopsy-proven cases from a single center in China,” International Journal of Rheumatic Diseases, vol. 21, no. 1, pp. 223–229, 2018. View at Publisher · View at Google Scholar
  17. M. Jasiek, A. Karras, V. Le Guern et al., “A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren’s syndrome,” Rheumatology, vol. 56, no. 3, pp. 362–370, 2017. View at Publisher · View at Google Scholar
  18. A. V. Goules, I. P. Tatouli, H. M. Moutsopoulos, and A. G. Tzioufas, “Clinically Significant Renal Involvement in Primary Sjögren's Syndrome: Clinical Presentation and Outcome,” Arthritis and Rheumatism, vol. 65, no. 11, pp. 2945–2953, 2013. View at Publisher · View at Google Scholar
  19. C. P. Mavragani and H. M. Moutsopoulos, “Sjӧgren’s syndrome,” Annual Review of Pathology: Mechanisms of Disease, vol. 9, no. 1, pp. 273–285, 2014. View at Publisher · View at Google Scholar
  20. A. Alunno, M. C. Leone, R. Giacomelli, R. Gerli, and F. Carubbi, “Lymphoma and Lymphomagenesis in Primary Sjögren’s Syndrome,” Frontiers in Medicine, vol. 5, p. 102, 2018. View at Publisher · View at Google Scholar
  21. A. V. Goules and A. G. Tzioufas, “Lymphomagenesis in Sjögren's syndrome: Predictive biomarkers towards precision medicine,” Autoimmunity Reviews, vol. 18, no. 2, pp. 137–143, 2019. View at Publisher · View at Google Scholar
  22. A. Papageorgiou, D. C. Ziogas, C. P. Mavragani et al., “Predicting the outcome of Sjogren’s syndrome-associated non-Hodgkin’s lymphoma patients,” PLoS One, vol. 10, no. 2, article e0116189, 2015. View at Publisher · View at Google Scholar
  23. M. V. Jonsson, P. Szodoray, S. Jellestad, R. Jonsson, and K. Skarstein, “Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjögren’s syndrome,” Journal of Clinical Immunology, vol. 25, no. 3, pp. 189–201, 2005. View at Publisher · View at Google Scholar
  24. A. J. Novak, S. L. Slager, Z. S. Fredericksen et al., “Genetic variation in B-cell-activating factor is associated with an increased risk of developing B-cell non-Hodgkin lymphoma,” Cancer Research, vol. 69, no. 10, pp. 4217–4224, 2009. View at Publisher · View at Google Scholar
  25. A. Nezos, A. Papageorgiou, G. Fragoulis et al., “B-Cell activating factor genetic variants in lymphomagenesis associated with primary Sjogren’s syndrome,” Journal of Autoimmunity, vol. 51, pp. 89–98, 2014. View at Publisher · View at Google Scholar
  26. S. Karakus, A. N. Baer, D. Agrawal, M. Gurakar, R. W. Massof, and E. K. Akpek, “Utility of novel autoantibodies in the diagnosis of Sjögren’s syndrome among patients with dry eye,” Cornea, vol. 37, no. 4, pp. 405–411, 2018. View at Publisher · View at Google Scholar
  27. E. K. Akpek, V. Y. Bunya, and I. J. Saldanha, “Sjögren’s Syndrome,” Cornea, vol. 38, no. 5, pp. 658–661, 2019. View at Publisher · View at Google Scholar
  28. J. L. Reyes, D. T. Vannan, B. Eksteen et al., “Innate and adaptive cell populations driving inflammation in dry eye disease,” Mediators of Inflammation, vol. 2018, Article ID 2532314, 12 pages, 2018. View at Publisher · View at Google Scholar
  29. G. Galperin, M. Berra, M. I. Marquez, M. Mandaradoni, J. Tau, and A. Berra, “Impact of environmental pollution on the ocular surface of Sjögren’s syndrome patients,” Arquivos Brasileiros de Oftalmologia, vol. 81, no. 6, pp. 481–489, 2018. View at Publisher · View at Google Scholar